Physician profile
Avi Shaw
NPI 1578144515
$5,565.87
in general payments reported to CMS, 2019-2025
19 companies · $3,147 in 2025
The $3,147 reported for 2025 was more than what 93% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $248 · 2022: $696 · 2023: $911 · 2024: $563 · 2025: $3,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668 · Travel and Lodging: $1,953.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,668.15 |
| Travel and Lodging | $1,953.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,987.75 | 2021-2025 | Scopis Ent |
| Inspire Medical Systems, INC. | $780.73 | 2024-2025 | Inspire |
| Acclarent, INC | $560.61 | 2022-2024 | Acclarent Aera |
| Glaxosmithkline, LLC. | $363.90 | 2022-2025 | Nucala |
| Davol INC. | $250.87 | 2022-2025 | Arista |
| Optinose US, INC. | $228.12 | 2022-2024 | |
| Atos Medical INC | $219.91 | 2023-2025 | Provox Life Home Hme |
| Genzyme Corporation | $205.02 | 2024 | |
| Integra Lifesciences Corporation | $177.03 | 2022-2023 | Tenoglide |
| Musculoskeletal Transplant Foundation INC. | $132.85 | 2021 | |
| Cochlear Americas | $119.32 | 2022-2025 | Osia Osi300 Implant, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha |
| Kerecis Limited | $115.90 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Checkpoint Surgical, INC | $114.61 | 2022 | |
| Axogen | $82.92 | 2021 | |
| Becton, Dickinson and Company | $81.43 | 2023 | Arista Ah Flexitip |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $78.79 | 2025 | Propel |
| Regeneron Healthcare Solutions, INC. | $29.09 | 2025 | Dupixent |
| Acera Surgical, INC. | $18.99 | 2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $18.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Avi Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.